Letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial
| Origin | Files produced by the author(s) |
|---|
Journal Articles
European Journal of Heart Failure
Year : 2022
Erwan BOZEC : Connect in order to contact the contributor
https://hal.univ-lorraine.fr/hal-03796760
Submitted on : Tuesday, October 4, 2022-3:22:34 PM
Last modification on : Monday, September 25, 2023-12:30:08 PM
Dates and versions
Identifiers
- HAL Id : hal-03796760 , version 1
- DOI : 10.1002/ejhf.2694
- PUBMED : 36114733
Cite
João Pedro Ferreira, João Sérgio Neves. Letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial. European Journal of Heart Failure, 2022, 24 (11), pp.2207. ⟨10.1002/ejhf.2694⟩. ⟨hal-03796760⟩
Collections
34
View
52
Download